These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1517560)

  • 1. The beta 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound.
    Parker KC; DiBrino M; Hull L; Coligan JE
    J Immunol; 1992 Sep; 149(6):1896-904. PubMed ID: 1517560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
    Pedersen LO; Stryhn A; Holter TL; Etzerodt M; Gerwien J; Nissen MH; Thøgersen HC; Buus S
    Eur J Immunol; 1995 Jun; 25(6):1609-16. PubMed ID: 7614989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of peptide binding to purified antibody-bound H-2Db and H-2Db beta 2m complexes.
    Burshtyn DN; Barber BH
    J Immunol; 1993 Sep; 151(6):3082-93. PubMed ID: 7690793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
    Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
    J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
    Parker KC; Bednarek MA; Coligan JE
    J Immunol; 1994 Jan; 152(1):163-75. PubMed ID: 8254189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous beta 2-microglobulin is required for antigenic peptide binding to isolated class I major histocompatibility complex molecules.
    Kane KP; Sherman LA; Mescher MF
    Eur J Immunol; 1991 Sep; 21(9):2289-92. PubMed ID: 1889467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High occupancy binding of antigenic peptides to purified, immunoadsorbed H-2Db beta 2m molecules.
    Burshtyn DN; Barber BH
    J Immunol; 1993 Sep; 151(6):3070-81. PubMed ID: 8397250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules.
    Olsen AC; Pedersen LO; Hansen AS; Nissen MH; Olsen M; Hansen PR; Holm A; Buus S
    Eur J Immunol; 1994 Feb; 24(2):385-92. PubMed ID: 8299688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
    Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
    J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism at position nine of the MHC class I heavy chain affects the stability of association with beta 2-microglobulin and presentation of a viral peptide.
    Ribaudo RK; Margulies DH
    J Immunol; 1995 Oct; 155(7):3481-93. PubMed ID: 7561043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different features of the MHC class I heterodimer have evolved at different rates. Chicken B-F and beta 2-microglobulin sequences reveal invariant surface residues.
    Kaufman J; Andersen R; Avila D; Engberg J; Lambris J; Salomonsen J; Welinder K; Skjødt K
    J Immunol; 1992 Mar; 148(5):1532-46. PubMed ID: 1538136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression.
    Otten GR; Bikoff E; Ribaudo RK; Kozlowski S; Margulies DH; Germain RN
    J Immunol; 1992 Jun; 148(12):3723-32. PubMed ID: 1602127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain.
    Lee L; McHugh L; Ribaudo RK; Kozlowski S; Margulies DH; Mage MG
    Eur J Immunol; 1994 Nov; 24(11):2633-9. PubMed ID: 7957555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA; Barber BH
    J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide interaction with a class I major histocompatibility complex-encoded molecule: allosteric control of the ternary complex stability.
    Gakamsky DM; Bjorkman PJ; Pecht I
    Biochemistry; 1996 Nov; 35(47):14841-8. PubMed ID: 8942647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class I/peptide interactions: binding specificity and kinetics.
    Margulies DH; Corr M; Boyd LF; Khilko SN
    J Mol Recognit; 1993 Jun; 6(2):59-69. PubMed ID: 8305252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.
    van der Burg SH; Visseren MJ; Brandt RM; Kast WM; Melief CJ
    J Immunol; 1996 May; 156(9):3308-14. PubMed ID: 8617954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines.
    Anderson KS; Alexander J; Wei M; Cresswell P
    J Immunol; 1993 Oct; 151(7):3407-19. PubMed ID: 8376783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the interactions between MHC class I subunits: a systematic approach for the engineering of higher affinity variants of beta 2-microglobulin.
    Shields MJ; Assefi N; Hodgson W; Kim EJ; Ribaudo RK
    J Immunol; 1998 Mar; 160(5):2297-307. PubMed ID: 9498770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.